chr1-22644037-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_172369.5(C1QC):āc.14C>Gā(p.Pro5Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000348 in 1,437,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_172369.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1QC | NM_172369.5 | c.14C>G | p.Pro5Arg | missense_variant | 2/3 | ENST00000374640.9 | NP_758957.2 | |
C1QC | NM_001114101.3 | c.14C>G | p.Pro5Arg | missense_variant | 2/3 | NP_001107573.1 | ||
C1QC | NM_001347619.2 | c.14C>G | p.Pro5Arg | missense_variant | 2/3 | NP_001334548.1 | ||
C1QC | NM_001347620.2 | c.-87+323C>G | intron_variant | NP_001334549.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1QC | ENST00000374640.9 | c.14C>G | p.Pro5Arg | missense_variant | 2/3 | 1 | NM_172369.5 | ENSP00000363771.4 | ||
ENSG00000289692 | ENST00000695747.1 | c.599C>G | p.Pro200Arg | missense_variant | 5/5 | ENSP00000512140.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000484 AC: 1AN: 206406Hom.: 0 AF XY: 0.00000902 AC XY: 1AN XY: 110836
GnomAD4 exome AF: 0.00000348 AC: 5AN: 1437526Hom.: 0 Cov.: 31 AF XY: 0.00000421 AC XY: 3AN XY: 712356
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 25, 2022 | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with C1QC-related conditions. This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 5 of the C1QC protein (p.Pro5Arg). This variant is present in population databases (no rsID available, gnomAD 0.004%). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 17, 2023 | BP4, PM2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at